MelissaKristenFreyMD
Obstetrics & Gynecology • New York, NYGynecologic Oncology, Minimally Invasive / Endoscopic Surgery, Urogynecology & Pelvic Reconstructive Surgery
Assistant Professor of Obstetrics and Gynecology in the division of gynecologic oncology at Weill Cornell Medicine
Dr. Frey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E 68th St
# 122
New York, NY 10065Phone+1 212-746-8490
Summary
- Dr. Melissa Frey is an obstetrician/gynecologist in New York, NY and is affiliated with New York-Presbyterian Hospital and Weill Cornell Medicine. She received her medical degree from Weill Cornell Medicine and has been in practice 8 years. She specializes in gynecologic oncology and cancer genetics.
Education & Training
NYU Grossman School of MedicineFellowship, Gynecologic Oncology, 2013 - 2016
New York Presbyterian Hospital (Cornell Campus)Residency, Obstetrics and Gynecology, 2009 - 2013
Weill Cornell MedicineClass of 2009
Certifications & Licensure
NY State Medical License 2013 - 2026- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- FaCT Trial (Facilitated Cascade Testing Trial) Start of enrollment: 2021 Jul 21
Publications & Presentations
PubMed
- 36 citationsRisk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition GenesYing L Liu, Kelsey Breen, Amanda Catchings, Megha Ranganathan, Alicia Latham
JCO Oncology Practice. 2021-09-28 - 45 citationsAchieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysisJenny Lin, Ravi Sharaf, Rachel Saganty, Danyal Ahsan, Julia Feit
Gynecologic Oncology. 2021-05-19 - 53 citationsCascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based ScreeningKenneth Offit, Kaitlyn Tkachuk, Zsofia K. Stadler, Michael Walsh, Hector Diaz-Zabala
Journal of Clinical Oncology. 2020-01-10
Journal Articles
- Prevalence of Nonfounder BRCA1/2 Mutations in Ashkenazi Jewish Patients Presenting for Genetic Testing at a Hereditary Breast and Ovarian Cancer CenterKevin Holcomb, Rohini V Kopparam, Melissa K Frey, Thomas Caputo, Cancer
Authored Content
- Articles & IssuesDecember 2018
Press Mentions
What You Should Know About Ovarian Cancer VaccinesNovember 16th, 2024- Faster, Easier, and More Anxiety-Inducing: Are DHTs Harming Patients' Mental Health?February 2nd, 2023
- Universal Genetic Testing Is Far from a Reality in Patients with Ovarian CancerJune 8th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
